139 related articles for article (PubMed ID: 21643987)
1. Analysis of DNA repair gene polymorphisms and survival in low-grade and anaplastic gliomas.
Berntsson SG; Wibom C; Sjöström S; Henriksson R; Brännström T; Broholm H; Johansson C; Fleming SJ; McKinney PA; Bethke L; Houlston R; Smits A; Andersson U; Melin BS
J Neurooncol; 2011 Dec; 105(3):531-8. PubMed ID: 21643987
[TBL] [Abstract][Full Text] [Related]
2. Comparative analyses of relative ERCC3 and ERCC6 mRNA levels in gliomas and adjacent non-neoplastic brain.
Dabholkar MD; Berger MS; Vionnet JA; Overton L; Thompson C; Bostick-Bruton F; Yu JJ; Silber JR; Reed E
Mol Carcinog; 1996 Sep; 17(1):1-7. PubMed ID: 8876669
[TBL] [Abstract][Full Text] [Related]
3. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
[TBL] [Abstract][Full Text] [Related]
4. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive impact of MGMT promoter methylation in grade 3 gliomas.
Haque W; Thong E; Andrabi S; Verma V; Brian Butler E; Teh BS
J Clin Neurosci; 2021 Mar; 85():115-121. PubMed ID: 33581781
[TBL] [Abstract][Full Text] [Related]
6. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
Sanson M; Marie Y; Paris S; Idbaih A; Laffaire J; Ducray F; El Hallani S; Boisselier B; Mokhtari K; Hoang-Xuan K; Delattre JY
J Clin Oncol; 2009 Sep; 27(25):4150-4. PubMed ID: 19636000
[TBL] [Abstract][Full Text] [Related]
7. Genetic Variants Related to Cell Cycle and Stability of Telomere in Patients with Glioma.
Calastri MCJ; Hattori G; Rodrigues NLTO; Gregorio ML; Brancati CIFO; Zanovelo EM; Ferraz Filho JRL; Neiva CM; Rodrigues Junior ACP; de Godoy MF; Lancellotti CLP; Tognola WA; Souza DRS
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2345-2351. PubMed ID: 31450905
[TBL] [Abstract][Full Text] [Related]
8. Association and interactions between DNA repair gene polymorphisms and adult glioma.
Liu Y; Scheurer ME; El-Zein R; Cao Y; Do KA; Gilbert M; Aldape KD; Wei Q; Etzel C; Bondy ML
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):204-14. PubMed ID: 19124499
[TBL] [Abstract][Full Text] [Related]
9. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
10. Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma.
Wiestler B; Capper D; Sill M; Jones DT; Hovestadt V; Sturm D; Koelsche C; Bertoni A; Schweizer L; Korshunov A; Weiß EK; Schliesser MG; Radbruch A; Herold-Mende C; Roth P; Unterberg A; Hartmann C; Pietsch T; Reifenberger G; Lichter P; Radlwimmer B; Platten M; Pfister SM; von Deimling A; Weller M; Wick W
Acta Neuropathol; 2014 Oct; 128(4):561-71. PubMed ID: 25008768
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of O6-methylguanine DNA methyltransferase (MGMT) promoter methylation in patients with low-grade gliomas.
Ochsenbein AF; Schubert AD; Vassella E; Mariani L
J Neurooncol; 2011 Jun; 103(2):343-51. PubMed ID: 20857319
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the DNA repair genes is predictive of outcome in lung cancer.
Matakidou A; el Galta R; Webb EL; Rudd MF; Bridle H; ; Eisen T; Houlston RS
Hum Mol Genet; 2007 Oct; 16(19):2333-40. PubMed ID: 17855454
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of DNA repair genes and chemosensitivity in 1p19q codeleted lower-grade gliomas.
Tang L; Deng L; Bai HX; Sun J; Neale N; Wu J; Wang Y; Chang K; Huang RY; Zhang PJ; Li X; Xiao B; Cao Y; Tao Y; Yang L
J Neurooncol; 2018 Sep; 139(3):563-571. PubMed ID: 29923053
[TBL] [Abstract][Full Text] [Related]
14. A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.
Jang BS; Kim IA
Radiother Oncol; 2018 Aug; 128(2):245-253. PubMed ID: 29784449
[TBL] [Abstract][Full Text] [Related]
15. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas.
Alentorn A; Marie Y; Carpentier C; Boisselier B; Giry M; Labussière M; Mokhtari K; Hoang-Xuan K; Sanson M; Delattre JY; Idbaih A
Neuro Oncol; 2012 Nov; 14(11):1393-403. PubMed ID: 23074200
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW
Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441
[TBL] [Abstract][Full Text] [Related]
18. Use of statins or NSAIDs and survival of patients with high-grade glioma.
Seliger C; Schaertl J; Gerken M; Luber C; Proescholdt M; Riemenschneider MJ; Leitzmann MF; Hau P; Klinkhammer-Schalke M
PLoS One; 2018; 13(12):e0207858. PubMed ID: 30507932
[TBL] [Abstract][Full Text] [Related]
19. Genomic copy number changes of DNA repair genes ERCC1 and ERCC2 in human gliomas.
Liang BC; Ross DA; Reed E
J Neurooncol; 1995 Oct; 26(1):17-23. PubMed ID: 8583241
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Molecular Recursive Partitioning Analysis of High-grade Glioma Treated With IMRT.
Sutera P; Kalash R; Flickinger J; Engh J; Heron DE
Am J Clin Oncol; 2019 Jan; 42(1):27-35. PubMed ID: 29912004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
